Amyris recently announced its Pathways Program is now available. The program provides partners with a low-cost, low-risk opportunity to access the company's synthetic biology technology.
Company news: Amyris and Safic-Alcan Win at Sepawa
With a small initial investment, the program allows partners to sponsor and secure a molecule they are interested in having Amyris produce, using the tools and technology being developed through the company's recently announced technology investment agreement.
